Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $675,041 - $914,790
2,506 New
2,506 $809,000
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $389,471 - $471,593
-712 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $363,604 - $458,136
712 New
712 $415,000
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $3.98 Million - $4.66 Million
-12,460 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $1.22 Million - $1.38 Million
4,008 Added 47.42%
12,460 $4.15 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $1,721 - $1,875
6 Added 0.07%
8,452 $2.64 Million
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $1.89 Million - $2.68 Million
8,446 New
8,446 $2.58 Million
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $758,244 - $1.06 Million
-3,445 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $996,569 - $1.12 Million
3,445 New
3,445 $1.08 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.